{"id":"doi:10.1093/asj/sjad211","kind":"article","title":"Public Interest in the Off-Label Use of Glucagon-like Peptide 1 Agonists (Ozempic) for Cosmetic Weight Loss: A Google Trends Analysis","authors":["Sabrina H. Han","Rachel H. Safeek","Kyle M. Ockerman","Nhan Trieu","Patricia Mars","Audrey Klenke","Heather J. Furnas","Sarah C. Sorice-Virk"],"author_count":8,"year":2023,"published":"2023-07-02","venue":"Aesthetic Surgery Journal","cited_by":209,"doi":"10.1093/asj/sjad211","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1093/asj/sjad211","archive_url":"https://space-kitty.com/papers/doi:10.1093/asj/sjad211","updated":null,"pmid":"37402640","pmcid":null,"openalex_id":"W4383186133","pdf_url":"https://academic.oup.com/asj/advance-article-pdf/doi/10.1093/asj/sjad211/51004228/sjad211.pdf","abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Pharmacology and Obesity Treatment"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[]}